MedAvail Holdings (STU:73M) PS Ratio: 0.76 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:73M MedAvail Holdings Inc STU:73M
12 GF Score
Price €11.05
View Full Analysis

What is MedAvail Holdings PS Ratio?

MedAvail Holdings STU:73M 12 PS Ratio is 0.76 as of Jul. 16, 2026. GuruFocus rates STU:73M with a GF Score™ of 12/100.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MedAvail Holdings's share price is €11.05. MedAvail Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €14.47. Hence, MedAvail Holdings's PS Ratio for today is 0.76.

The historical rank and industry rank for MedAvail Holdings's PS Ratio or its related term are showing as below:

STU:73M's PS Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.51
* Ranked among companies with meaningful PS Ratio only.

MedAvail Holdings's Revenue per Sharefor the three months ended in Jun. 2023 was €0.21. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €14.47.

Back to Basics: PS Ratio


MedAvail Holdings  (STU:73M) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


MedAvail Holdings PS Ratio Related Terms


MedAvail Holdings PS Ratio Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings PS Ratio Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
PS Ratio
0.00 6.14 2.07 0.46

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.70 2.04 0.46 0.95 0.83

STU:73M vs HEWA, BIMI, MEDS: PS Ratio Comparison

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAvail Holdings PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's PS Ratio falls into.


STU:73M
12GF Score
MedAvail Holdings Inc STU:73M
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

MedAvail Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=11.05/14.474
=0.76

MedAvail Holdings's Share Price of today is €11.05.
MedAvail Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €14.47.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.76 mean?
MedAvail Holdings (STU:73M) has a PS Ratio of 0.76 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MedAvail Holdings and its competitors.
Is MedAvail Holdings' PS Ratio too high?
MedAvail Holdings' current PS Ratio is 0.76. The Healthcare Providers & Services industry median PS Ratio is 1.51. MedAvail Holdings' value of 0.76 is 49.7% below this industry median. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' PS Ratio compare to HEWA and BIMI?
MedAvail Holdings' PS Ratio of 0.76 can be compared against companies in the Healthcare Providers & Services industry. The industry median PS Ratio is 1.51. MedAvail Holdings' value of 0.76 is 49.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedAvail Holdings's current PS Ratio of 0.76 is 49.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MedAvail Holdings and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedAvail Holdings's current PS Ratio is 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (STU:73M) has a current PS Ratio of 0.76. The current PS Ratio is 0.76 and 49.7% below the Healthcare Providers & Services industry median of 1.51. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For MedAvail Holdings (STU:73M), the current PS Ratio is 0.76 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for STU:73M

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.05
Price